082270.KQ KOE
GemVax&KAEL Co.,Ltd
1W: +4.4%
1M: +3.8%
3M: -9.4%
YTD: -72.0%
1Y: -80.0%
3Y: -16.5%
5Y: -48.0%
₩11,150.00 ($8.31)
-60.00 (-0.54%)
Weekly Expected Move ±6.9%
₩9613
₩10382
₩11150
₩11918
₩12687
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$158.9B
+5.4% ▲
5Y CAGR: +0.0%
Total Liabilities
$101.6B
-16.5% ▼
5Y CAGR: +33.9%
Shareholders Equity
$57.2B
+97.3% ▲
5Y CAGR: -15.8%
Cash & Investments
$24.8B
+240.6% ▲
5Y CAGR: -14.6%
Total Debt
$58.1B
-18.3% ▼
5Y CAGR: +45.0%
Net Debt
$40.5B
-40.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $18.7B | $15.8B | $16.5B | $3.6B | $17.6B |
| Short-Term Investments | $16.8B | $27.0B | $4.2B | $3.7B | $7.2B |
| Cash & ST Investments | $35.5B | $42.8B | $20.7B | $7.3B | $24.8B |
| Net Receivables | $6.8B | $3.8B | $4.8B | $11.7B | $7.0B |
| Inventory | $7.5B | $10.8B | $6.8B | $5.7B | $8.7B |
| Other Current Assets | $2.6B | $2.3B | $1.2B | $0 | $0 |
| Total Current Assets | $52.6B | $60.1B | $33.7B | $25.2B | $42.9B |
| Property, Plant & Equip. | $26.3B | $32.5B | $37.5B | $36.6B | $33.0B |
| Goodwill & Intangibles | $7.4B | $8.2B | $5.0B | $3.3B | $3.4B |
| Long-Term Investments | $66.3B | $20.3B | $52.4B | $49.5B | $79.0B |
| Other Non-Current Assets | $72M | $72M | $6.5B | $36.2B | $625M |
| Total Non-Current Assets | $119.7B | $91.0B | $101.4B | $125.6B | $116.0B |
| Total Assets | $172.3B | $151.1B | $135.2B | $150.7B | $158.9B |
| — Liabilities — | |||||
| Accounts Payable | $2.5B | $1.5B | $2.0B | $2.1B | $2.7B |
| Short-Term Debt | $5.3B | $6.1B | $13.5B | $48.1B | $47.9B |
| Deferred Revenue | $7.7B | $7.7B | $0 | $0 | $630M |
| Other Current Liabilities | $0 | $0 | $4.3B | $9.7B | $14.2B |
| Total Current Liabilities | $16.1B | $15.8B | $26.0B | $70.3B | $65.4B |
| Long-Term Debt | $1M | $0 | $1M | $22.5B | $10.0B |
| Other Non-Current Liab. | $1.4B | $453M | $650M | $28.8B | $26.0B |
| Total Non-Current Liabilities | $2.2B | $967M | $1.1B | $51.5B | $36.2B |
| Total Liabilities | $18.4B | $16.8B | $27.1B | $121.7B | $101.6B |
| — Equity — | |||||
| Common Stock | $19.9B | $19.9B | $20.0B | $20.0B | $21.3B |
| Retained Earnings | -$46.7B | -$65.8B | -$94.1B | -$183.4B | -$78.4B |
| Accumulated OCI | -$2.8B | $2.5B | $2.4B | $0 | $4.9B |
| Total Stockholders Equity | $154.0B | $134.4B | $108.0B | $29.0B | $57.2B |
| Total Liabilities & Equity | $172.3B | $151.1B | $135.2B | $150.7B | $158.9B |
| — Key Metrics — | |||||
| Total Debt | $6.7B | $7.2B | $14.5B | $71.1B | $58.1B |
| Net Debt | -$12.0B | -$8.6B | -$2.0B | $67.5B | $40.5B |
| Total Investments | $83.1B | $47.3B | $56.6B | $53.2B | $86.2B |